Literature DB >> 8527826

Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures.

A A Welder1, J W Robertson, R B Melchert.   

Abstract

Hepatic complications in athletes and bodybuilders after abusing anabolic-androgenic steroids (AAS) have been reported. Hepatic injury, including cholestasis, peliosis hepatis, hyperplasia, and tumors, have been attributed to abuse of the 17 alpha-alkylated AAS. Some of these pathological conditions have been reversed when individuals were converted to nonalkylated AAS regimens. The purpose of this study was to determine and compare the direct toxic effects of commonly abused AAS (both 17 alpha-alkylated and nonalkylated) in primary hepatic cell cultures. Primary cultures, established from 60-day-old Sprague-Dawley rats, were exposed to doses of 1 x 10(-8), 1 x 10(-6), and 1 x 10(-4)M 19-nortestosterone, fluoxymesterone, testosterone cypionate, stanozolol, danazol, oxymetholone, testosterone, estradiol, and methyltestosterone for 1, 4, and 24 hr. Lactate dehydrogenase (LDH) release, neutral red (NR) retention, and glutathione (GSH) depletion were evaluated to determine plasma membrane damage, cell viability, and possible oxidative injury, respectively. Those cultures exposed to the 17 alpha-alkylated AAS, methyltestosterone and stanozolol, at doses of 1 x 10(-4) M for 24 hr and the 17 alpha-alkylated AAS, oxymetholone, at 1 x 10(-4) M for 4 and 24 hr showed significant increased in LDH release and decreases in NR retention while there were no significant differences with the nonalkylated steroids (testosterone cypionate, 19-nortestosterone, testosterone, and estradiol). GSH depletion was evaluated in cultures treated with 1 x 10(-8), 1 x 10(-6), and 1 x 10(-4) M concentrations of methyltestosterone, stanozolol, and oxymetholone for 1, 2, 4, and 6 hr. Cultures exposed to 1 x 10(-4) M oxymetholone were significantly depleted of GSH at 2, 4, and 6 hr; cultures exposed to 1 x 10(-4) M methyltestosterone were significantly depleted of GSH at 4 and 6 hr; and cultures exposed to stanozolol were not significantly depleted of GSH at any of the time periods tested. These data indicate that the 17 alpha-alkylated steroids (methyltestosterone, oxymetholone, and stanozolol) are directly toxic to hepatocytes, whereas the nonalkylated steroids (testosterone cypionate, 19-nortestosterone, testosterone, and estradiol) show no effects at similar doses. These data demonstrate a trend toward a structural-activity relationship to AAS-induced toxicity in primary cultures of rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527826     DOI: 10.1016/1056-8719(94)00073-d

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  10 in total

1.  Effects of synthetic androgens on liver function using the rabbit as a model.

Authors:  Sheri Ann Hild; Barbara J Attardi; Sailaja Koduri; Bruce A Till; Jerry R Reel
Journal:  J Androl       Date:  2010-04-08

Review 2.  Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders.

Authors:  Vittorio Fineschi; Irene Riezzo; Fabio Centini; Enrico Silingardi; Manuela Licata; Giovanni Beduschi; Steven B Karch
Journal:  Int J Legal Med       Date:  2005-11-15       Impact factor: 2.686

Review 3.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

4.  Biochemical and oxidative stress markers in the liver and kidneys of rats submitted to different protocols of anabolic steroids.

Authors:  Guilherme Lopes Dornelles; Andressa Bueno; Juliana Sorraila de Oliveira; Aleksandro Schafer da Silva; Raqueli Teresinha França; Cássia Bagolin da Silva; Márcia Silveira Netto Machado; Letícia do Santos Petry; Fátima Husein Abdalla; Cibele Lima Lhamas; Cinthia Melazzo de Andrade
Journal:  Mol Cell Biochem       Date:  2016-11-28       Impact factor: 3.396

5.  Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis.

Authors:  Sayeepriyadarshini Anakk; Mitsuhiro Watanabe; Scott A Ochsner; Neil J McKenna; Milton J Finegold; David D Moore
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

Review 6.  Anabolic steroids and cardiovascular risk.

Authors:  Peter Angell; Neil Chester; Danny Green; John Somauroo; Greg Whyte; Keith George
Journal:  Sports Med       Date:  2012-02-01       Impact factor: 11.136

Review 7.  Testosterone Replacement Therapy in Hypogonadal Men.

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.741

8.  Differential protein expression profile in the hypothalamic GT1-7 cell line after exposure to anabolic androgenic steroids.

Authors:  Freddyson J Martínez-Rivera; Juliana Pérez-Laspiur; María E Santiago-Gascot; Abner G Alemán-Reyes; Emanuel García-Santiago; Yolanda Rodríguez-Pérez; Cristhian Calo-Guadalupe; Inelia Otero-Pagán; Roxsana N Ayala-Pagán; Magdiel Martínez; Yisel M Cantres-Rosario; Loyda M Meléndez; Jennifer L Barreto-Estrada
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

9.  A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States.

Authors:  Jason Cohen; Rick Collins; Jack Darkes; Daniel Gwartney
Journal:  J Int Soc Sports Nutr       Date:  2007-10-11       Impact factor: 5.150

10.  Targeted Metabolomics to Assess Exposure to Environmental Chemicals of Concern in Japanese Quail at Two Life Stages.

Authors:  Elena Legrand; Niladri Basu; Markus Hecker; Doug Crump; Jianguo Xia; Bharat Chandramouli; Heather Butler; Jessica A Head
Journal:  Metabolites       Date:  2021-12-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.